Sale!

GCK Gene Maturity-onset Diabetes of the Young Type 2 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GCK Gene Maturity-onset Diabetes of the Young Type 2 (MODY2) Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to detect mutations in the GCK gene. These mutations are responsible for MODY2, a form of diabetes that typically manifests at a young age but differs from the more common types 1 and 2 diabetes in its causes and treatment approaches. MODY2 is characterized by a mild increase in blood sugar levels, often detected in adolescence or early adulthood. The test plays a crucial role in accurately diagnosing MODY2, enabling tailored treatment plans that can significantly improve patient outcomes. Priced at 4400 AED, this genetic test is a valuable investment for individuals with a family history of MODY or those exhibiting symptoms of diabetes at a young age, offering them a clear understanding of their condition and guiding them towards the most effective management strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

GCK Gene Maturity-onset diabetes of the young type 2 Genetic Test

Test Details

The GCK gene, also known as glucokinase gene, is associated with maturity-onset diabetes of the young type 2 (MODY2). MODY2 is a form of diabetes that is caused by a mutation in the GCK gene, resulting in impaired glucose sensing and regulation in the pancreas.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the sequencing of multiple genes simultaneously. In the context of MODY2, an NGS genetic test can be performed to identify any mutations or variations in the GCK gene that may be contributing to the development of the condition.

The NGS genetic test for MODY2 typically involves obtaining a blood or saliva sample from the individual undergoing testing. The DNA from the sample is then extracted and sequenced using NGS technology. The resulting sequence data is analyzed to identify any variations or mutations in the GCK gene.

The test results can provide valuable information about an individual’s genetic predisposition to MODY2. This information can be used for diagnostic purposes, as well as for guiding treatment and management strategies for individuals with MODY2 or those at risk of developing the condition.

It is important to note that genetic testing for MODY2 is typically recommended for individuals with a family history of diabetes, particularly those with a history of early-onset diabetes and a pattern of inheritance suggestive of MODY. Genetic counseling is often recommended before and after genetic testing to ensure individuals fully understand the implications and limitations of the test results.

Test Name

GCK Gene Maturity-onset diabetes of the young type 2 Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for GCK Gene Maturity-onset diabetes of the young type 2 NGS Genetic DNA Test

A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young type 2

Test Name GCK Gene Maturity-onset diabetes of the young type 2 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for GCK Gene Maturity-onset diabetes of the young type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Maturity-onset diabetes of the young type 2
Test Details

The GCK gene, also known as glucokinase gene, is associated with maturity-onset diabetes of the young type 2 (MODY2). MODY2 is a form of diabetes that is caused by a mutation in the GCK gene, resulting in impaired glucose sensing and regulation in the pancreas.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the sequencing of multiple genes simultaneously. In the context of MODY2, an NGS genetic test can be performed to identify any mutations or variations in the GCK gene that may be contributing to the development of the condition.

The NGS genetic test for MODY2 typically involves obtaining a blood or saliva sample from the individual undergoing testing. The DNA from the sample is then extracted and sequenced using NGS technology. The resulting sequence data is analyzed to identify any variations or mutations in the GCK gene.

The test results can provide valuable information about an individual’s genetic predisposition to MODY2. This information can be used for diagnostic purposes, as well as for guiding treatment and management strategies for individuals with MODY2 or those at risk of developing the condition.

It is important to note that genetic testing for MODY2 is typically recommended for individuals with a family history of diabetes, particularly those with a history of early-onset diabetes and a pattern of inheritance suggestive of MODY. Genetic counseling is often recommended before and after genetic testing to ensure individuals fully understand the implications and limitations of the test results.